Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm [Phase 1]
Phase 1 pharmacokinetics and relative bioavailability study of bococizumab (PF-04950615; RN316) when administered to abdomen, thigh, or uppe…
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients [Phase 4]
Phase 4 trial comparing ROVASRO 10mg to CRESTOR 10mg in hypercholesterolemia; study completed.
-
FDA approval · 2019-05-07FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Shandong New Time Pharmaceutical Co., Ltd.)
FDA approved the original application for rosuvastatin calcium (generic rosuvastatin) from Shandong New Time Pharmaceutical Co., Ltd., expan…
-
FDA approval · 2019-04-24FDA Approved: ROSUVASTATIN — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved the original ANDA for a generic rosuvastatin product, manufactured by ScieGen Pharmaceuticals, Inc.
-
FDA approval · 2019-04-09FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Umedica Laboratories USA Inc.)
FDA approved a generic rosuvastatin calcium product from Umedica Laboratories USA Inc. under an Original Application (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-03FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA approved Cranbury Pharmaceuticals, LLC's supplemental application for Rosuvastatin Calcium, authorizing a generic rosuvastatin calcium p…
-
FDA approval · 2019-04-02FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy [Phase 2]
Phase 2 trial evaluating ETC-1002 vs placebo in patients on ongoing statin therapy for hypercholesterolemia has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia [Phase 2]
Phase 2 clinical trial assessing safety, pharmacokinetic interactions, and efficacy of ETC-1002 with atorvastatin in hypercholesterolemia co…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients [Phase 2]
Phase 2 trial update evaluating ETC-1002 (bempedoic acid), ezetimibe, and their combination in patients with hypercholesterolemia; study com…
-
FDA approval · 2019-03-22FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approves a supplemental application for the ezetimibe and simvastatin combination by Amneal, indicating a modification to an already-app…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab [Phase 3]
Open-label extension study assessing safety and efficacy of evolocumab in hypercholesterolemia completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol [Phase 3]
Phase 3 trial evaluating two regimens of mipomersen in patients with familial hypercholesterolemia and inadequately controlled LDL cholester…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: A Study of LY3015014 in Healthy Participants With High Cholesterol [Phase 1]
Phase 1 trial update for LY3015014 in healthy participants with high cholesterol has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction [Phase 2]
Phase 2 study evaluating LIB003 for additional LDL-C reduction in patients on lipid-lowering therapy has completed. The trial assessed effic…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Effects of Nutraceutical Therapies on Endothelial Function, Platelet Aggregation, and Coronary Flow Reserve [NA]
This clinical trial update reports on a completed study evaluating nutraceutical therapies for endothelial function, platelet aggregation, a…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood [Phase 3]
Phase 3 trial evaluating a palm oil-derived supplement for lowering blood cholesterol in hypercholesterolemia was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects [Phase 2]
Pfizer conducted a Phase 2 dose-ranging study of bococizumab in Japanese patients with hypercholesterolemia; the trial has completed and res…
-
FDA approval · 2019-02-08FDA Approved: ATORVASTATIN CALCIUM — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the first original application for atorvastatin calcium as a generic product from Novadoz Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia [Phase 1]
A Phase 1 study evaluated the safety and tolerability of multiple doses of PF-04950615 (RN316) in adults with hypercholesterolemia. The stud…
-
FDA approval · 2018-12-31FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin from NorthStar Rx LLC, updating the approved generic product's labeling/manufacturin…
-
FDA approval · 2018-12-21FDA Approved: ATORVASTATIN CALCIUM — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' atorvastatin calcium as an original generic application, authorizing a new generic version of atorvast…
-
FDA approval · 2018-12-18FDA Approved: EZALLOR SPRINKLE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved EZALLOR SPRINKLE (rosuvastatin) under Sun Pharmaceutical Industries, Inc.'s Original Application, introducing a sprinkle-form r…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833) [Phase 3]
A completed Phase 3 trial assessing the long-term safety and tolerability of MK-0653H in Japanese participants with hypercholesterolemia; re…
-
FDA approval · 2018-11-20FDA Approved: ATORVASTATIN CALCIUM — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for atorvastatin calcium from Zydus Lifesciences Limited, granting generic approval for lowering chole…